Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB-DYYB Cause Weight increased? 2,848 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 2,848 reports of Weight increased have been filed in association with INFLIXIMAB-DYYB (ZYMFENTRA). This represents 11.1% of all adverse event reports for INFLIXIMAB-DYYB.

2,848
Reports of Weight increased with INFLIXIMAB-DYYB
11.1%
of all INFLIXIMAB-DYYB reports
61
Deaths
822
Hospitalizations

How Dangerous Is Weight increased From INFLIXIMAB-DYYB?

Of the 2,848 reports, 61 (2.1%) resulted in death, 822 (28.9%) required hospitalization, and 24 (0.8%) were considered life-threatening.

Is Weight increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB-DYYB. However, 2,848 reports have been filed with the FAERS database.

What Other Side Effects Does INFLIXIMAB-DYYB Cause?

Off label use (14,256) Condition aggravated (10,275) Intentional product use issue (7,549) Inappropriate schedule of product administration (5,977) Arthralgia (4,615) Drug ineffective (3,112) Fatigue (3,111) Malaise (2,766) Weight decreased (2,703) Blood pressure increased (2,309)

What Other Drugs Cause Weight increased?

ADALIMUMAB (7,724) INFLIXIMAB (7,639) PREDNISONE (7,348) RISPERIDONE (6,885) METHOTREXATE (6,616) TOCILIZUMAB (6,425) RITUXIMAB (6,148) TOFACITINIB (5,342) ETANERCEPT (5,327) PREGABALIN (4,903)

Which INFLIXIMAB-DYYB Alternatives Have Lower Weight increased Risk?

INFLIXIMAB-DYYB vs INFLIXIMAB-QBTX INFLIXIMAB-DYYB vs INFLIXIMAB, RECOMBINANT INFLIXIMAB-DYYB vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B

Related Pages

INFLIXIMAB-DYYB Full Profile All Weight increased Reports All Drugs Causing Weight increased INFLIXIMAB-DYYB Demographics